Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

230 Views

Poster Session: Infections in Immunocompromised Individuals

2098 - Cytomegalovirus (CMV) Infection Following Hematopoietic Cell Transplantation (HCT) with Post-transplant Cyclophosphamide (PTCy): Outcomes in Haploidentical versus Matched or Mismatched Unrelated Donor (MUD/MMURD) Allografts

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

Jessica S. Little, MD

Transplant Infectious Diseases Fellow
Brigham and Women's Hospital
Boston, Massachusetts, United States

Co-Author(s)

JN

Jian Ni, Pharm.D.

Brigham and Women's Hospital
Boston, Massachusetts, United States
RS

Roman M. Shapiro, M.D.

Dana-Farber Cancer Institute
Boston, Massachusetts, United States
RR

Rizwan Romee, M.D.

Dana-Farber Cancer Institute
Boston, Massachusetts, United States
RS

Robert J. Soiffer, M.D.

Dana-Farber Cancer Institute
Boston, Massachusetts, United States
AS

Amy C. Sherman, MD

Instructor, Harvard Medical School
Brigham and Women's Hospital
Boston, Massachusetts, United States
VH

Vincent T. T. Ho, M.D.

Doctor
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
NI

Nicolas C. Issa, MD

M.D
Brigham & Women's Hospital
Boston, Massachusetts, United States